An MRI instead of a surgical procedure helped speed up the wait between diagnosis and treatment, UK research has found ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports.

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...

Biotech giant Gilead Sciences, Inc. GILD has put up a strong performance amid a volatile market. Shares of this biotech giant ...

A Keighley deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...